A phase II trial of temsirolimus in metastatic neuroendocrine carcinomas (NECs). Conferences

authors

• Duran, I
• Le, L
• Saltman, D
• Kortmansky, J
• Kocha, W
• Singh, D
• Pond, Gregory
• Peralba, JM
• Dancey, J
• Siu, LL

status

• published 

publication date

• June 1, 2005

has subject area

• 1103 Clinical Sciences (FoR)
• 1112 Oncology and Carcinogenesis (FoR)
• Oncology & Carcinogenesis (Science Metrix)

published in

• Journal of Clinical Oncology  Journal

presented at event

• 41st Annual Meeting of the American-Society-of-Clinical-Oncology  Conference

keywords

• Life Sciences & Biomedicine
• Oncology
• Science & Technology

start page

• 215S

end page

• 215S

volume

• 23

issue

• 16